This podcast discusses the top 10 things you should remember from the 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. Newer evidence has been published since the publication of the 2013 cholesterol guidelines and even since the Expert Consensus Decision Pathway that was published in 2016. This pathway addressed the following patient subgroups: patients with clinical atherosclerotic cardiovascular disease, patients with very high levels of low-density lipoprotein, high-risk patients with diabetes, and high-risk patients for primary prevention.

Subscribe on iTunes | Subscribe on Google Play | View in the Educational Activity

Keywords: Cholesterol, LDL, Antibodies, Monoclonal, Primary Prevention, Risk Assessment, Atherosclerosis, Dyslipidemias, CardiaCast

< Back to Listings